Dalibor Sames

Professor of Chemistry at Columbia University

Papers

5 publications

Trials

0 clinical trials

Links

Key Impact

He is a leading medicinal/organic chemist whose group has helped define the pharmacology and synthetic development of ibogaine and iboga analogs in psychedelic and neurotherapeutic research.

Background & Research

Dalibor Sames is a Professor of Chemistry at Columbia University and a member of the Zuckerman Mind Brain Behavior Institute. His research combines organic synthesis, molecular design, and pharmacology to study neuroplasticity-promoting compounds, with major work on ibogaine, iboga alkaloids, tianeptine, kratom, and related CNS therapeutics. He earned his degrees at Charles University in Prague and the University of Arizona and completed postdoctoral research at Memorial Sloan Kettering Cancer Center.

5

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

3 collaborators· click a node to visit their profile

Full network →